B O O K - American College of Rheumatology

saturday
ACR Certified Rheumatology Coder
Course – Day One cP
9:00 am - 5:00 pm
B313
Admission to the ACR Certified Rheumatology Coder Course
requires a separate registration. Registration includes CRHC
review materials, examination and a boxed lunch. This course is
not eligible for CME credit.
Speakers: Antanya Chung; American College of Rheumatology;
Atlanta, GA
Melesia Tillman; American College of Rheumatology; Atlanta, GA
Session Overview:
The US Department of Labor anticipates the demand for
individuals with a solid background in medical coding will
increase as physician practices and hospitals continue to require
accurate coding for appropriate reimbursement and to reduce
audit risk. To help address this need, the American College of
Rheumatology, in collaboration with the American Academy
of Professional Coders, has developed a rheumatology coding
specialty credential to help coders demonstrate a superior
level of expertise in the field of rheumatology. To receive the
credential, coders must participate in the two-day rheumatology
coding course and pass the examination. The course is designed
to increase coding knowledge and help participaants prepare for
the examination.
Upon completion of this session, participants should be able to:
• exhibit proficiency in adjudicating claims for accurate medical
coding for diagnoses, procedures, and services
• demonstrate knowledge of medical coding rules and
regulations along with keeping current on issues regarding
medical coding, compliance, and reimbursement for
rheumatology services
• discuss human anatomy, physiology, and medical terminology
commensurate with ability to correctly code provider services
and diagnoses
extends beyond their capacity to produce immunoglobulin.
Their involvement in the initiation and regulation of the
adaptive immune response comprises a burgeoning topic of
research. There has been intense interest in recent years in the
participation of B-cells in autoimmune disease. In addition, it is
increasingly recognized that regulatory B-cells may participate
in numerous settings to down-regulate the immune response.
These disparate aspects of B-cell biology are of high interest
for potential application to the treatment of inflammation and
autoimmunity.
Upon completion of this session, participants should be able to:
• identify key concepts and major advances in B cell biology,
including B cell development and regulation
• explain approaches used to identify and quantify B cell
subpopulations
• describe examples of rheumatic diseases where B cells play
important roles in pathogenesis
• list the major pathways involved in B cell signaling
• recite the concepts and rationale underlying the use of B celldirected
therapies in autoimmune disease
• state the major findings from clinical trials using B celldirected
therapies in rheumatic disease
• describe the challenges faced in therapeutic targeting of B
cells, including potential toxicities
1:00 PM
Introduction
B cells: An Evolutionary and Historic Perspective
Max D. Cooper, MD; Emory University School of Medicine;
Atlanta, GA
Session I: B cell Development
Moderator: Shiv Pillai, MD, PhD; Massachusetts General
Hospital; Boston, MA
1:45 PM
Early B cell Development
Paul Kincade, PhD; Oklahoma Medical Research Foundation;
Oklahoma City, OK
ACR Basic Research Conference –
dAy One R
1:00 - 5:30 pm
B402
Admission to the ACR Basic Research Conference requires a
separate registration.
The Immunobiology of B Cells: From Antibodies to
Immunoregulation
Moderators: Ann Marshak-Rothstein, PhD; University of
Massachusetts Medical School; Worcester, MA
E. William St.Clair, MD; Duke University Medical Center; Durham,
NC
Session Overview:
B cells are a heterogeneous subset of lymphocytes that are
classically studied for their participation in humoral immunity.
However, it is becoming increasingly apparent that B-cell
participation in immune responses and in autoimmunity
2:20 PM
Molecular Regulation of B cell Subsets and Their Development
Richard Hardy, PhD; Fox Chase Cancer Center; Philadelphia, PA
2:55 PM
B cell Receptor Stimulation and Lineage Decisions
Shiv Pillai, MD, PhD; Massachusetts General Hospital; Boston,
MA
3:30 - 3:45 PM
Break
Session II: B cell Activation and Trafficking
Moderator: David Rawlings, MD; University of Washington;
Seattle, WA
3:45 PM
B cell Receptor and Signaling Pathways
David Rawlings, MD; University of Washington; Seattle, WA
20
2010 Program Book